StreetAlpha.app
Home › Stocks › KMTS

Kestra Medical Technologies, Ltd. (KMTS)

$25.10
▼ −5.75%
LAST CLOSE · NOV 20

Kestra Medical Technologies makes the ASSURE wearable defibrillator and a connected monitoring platform for heart patients. It last closed at $25.10 on Nov 20, down 5.75% on the day. The next earnings report for KMTS is expected around Mon, Nov 30, 2026. For the quarter ended Jul 2026, KMTS reported EPS of -$0.75 on revenue of $31.0M, with revenue up 59.9% from a year ago. Over its last 7 reports the stock moved an average of 6.9% the session after earnings. Over the last 12 months KMTS insiders bought $200K of stock on the open market and sold $16.0M, according to SEC Form 4 filings.

AI Auto Pilots
Is KMTS in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold KMTS.

Key Stats

Last 12 months
Results
Revenue
$106.7M
+60.7% vs a year ago
Net income
−$149.9M
−140.4% margin
EPS (diluted)
−$2.68
Free cash flow
−$122.8M
−115.0% margin
Valuation
Market cap
$1.5B
59.6M shares
P/E
–
No P/E while losing money
Price to sales
14.0
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$68.6M
At Jul 31
Debt
$72.5M
At Jul 31
Shares outstanding
59.6M
At Sep 11
Fiscal year endsApril
ExchangeNasdaq
Financials history
FY2024: $27.8M$27.8MFY2024FY2025: $59.8M$59.8MFY2025FY2026: $95.1M$95.1MFY2026

From KMTS's SEC filings, latest 10-Q for the period ending Jul 31, 2026 (filed Sep 14). Last 12 months adds up the four latest quarters.

Next report
Nov 30
Estimated date · Time not announced
Reported EPS
-$0.75
Quarter ended Jul 2026
Year ago EPS
-$0.50
Same quarter last year
Revenue
$31.0M
+59.9% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Oct 2024: -$1.19Oct '24Jan 2025: -$1.25Jan '25Apr 2025: -$1.57Apr '25Jul 2025: -$0.50Jul '25Oct 2025: -$0.64Oct '25Jan 2026: -$0.61Jan '26Apr 2026: -$0.67Apr '26Jul 2026: -$0.75Jul '26Latest -$0.75
Revenue by quarter
Oct 2024: $14.7MOct '24Jan 2025: $15.1MJan '25Apr 2025: $17.2MApr '25Jul 2025: $19.4MJul '25Oct 2025: $22.6MOct '25Jan 2026: $24.6MJan '26Apr 2026: $28.6MApr '26Jul 2026: $31.0MJul '26Latest $31.0M
How KMTS moved after its last 7 reports
Average move the session after a report ±6.9%
Sep 14, 2026After the close+4.7%
Jul 14, 2026After the close+1.8%
Mar 17, 2026After the close−7.4%
Dec 1, 2025Time not announced−8.5%
Sep 11, 2025After the close+18.6%
Jul 15, 2025After the close−5.8%
Apr 14, 2025After the close+1.3%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on KMTSStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on KMTS
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on KMTS

Technical Analysis

KMTS · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold

The stock is 16% below its 20 day and 10% below its 50 day average. It is 4% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 38), near oversold. The nearest support is the Pivot S1 at $24.19, and the nearest resistance the swing high (Sep 15) at $25.44.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 7.4%/day
Key levels
$31.9952 week high+27.5%
$29.0520 day average+15.7%
$27.6850 day average+10.3%
$26.75Pivot R1+6.6%
$26.52100 day average+5.7%
$25.84Pivot+2.9%
$25.44Swing high (Sep 15)+1.4%
$25.10Last close
$24.19Pivot S1−3.6%
$24.13200 day average−3.9%
$22.11Swing low (Jul 31)−11.9%
$17.3452 week low−30.9%
Indicators
RSI (14)37.70Weak, oversold below 30Neutral
MACD-0.26Below its signal lineBearish
Stochastic7.8Near the bottom of its rangeOversold
ADX (14)15.6No clear trend
Williams %R-97.7Oversold below −80, overbought above −20Oversold
CCI (20)-238.8Oversold below −100, overbought above 100Oversold
Rate of change−12.8%Change over 10 sessionsBearish
ATR (14)$1.86Typical daily range, 7.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for KMTS

What happened before

See how KMTS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Whale Options Flow

90D
Whale options flow for KMTSHow many large options trades hit KMTS, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

KMTS Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲66 buying vs 39 selling
  • ●Held by funds +0.3 pts
  • ▲Funds holding +13
  • ▼Superinvestors: 1 added, 2 cut
  • ●Put/call not meaningful
Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding122109+11.9%
In funds' top 10440.0%
Held by funds98.9%98.6%+0.3 pts
New / increased23 / 4314 / 54−2.9%
Reduced / sold out29 / 1020 / 8+39.3%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See KMTS institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

KMTS Insider Trading

All filings →
Insider trading · 12 months
Insiders are net sellers
Bought$200K1 buy · 1 insider
Sold$16.0M32 sales · 11 insiders
70% of the selling was under pre-arranged trading plans.
2025-12 sold $679K2026-01 sold $342K2026-02 sold $384K2026-03 bought $200K2026-03 sold $304K2026-04 sold $301K2026-05 sold $314K2026-06 sold $312K2026-07 sold $337K2026-08 sold $5.4M2026-09 sold $609K2026-10 sold $6.5M2026-11 sold $521KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 18Brian Daniel WebsterSee RemarksSale plan15,000$28.46$427K
Nov 3Timothy P. MoranChief Business OfficerSale3,192$29.56$94K
Oct 29Vaseem MahboobCFOSale plan79,500$30.30$2.4M
Oct 27Traci S UmbergerSee RemarksSale plan30,000$30.03$901K
Oct 21Traci S UmbergerSee RemarksSale plan100,000$27.18$2.7M
Oct 20Brian Daniel WebsterSee RemarksSale plan15,000$29.56$443K
Every insider buy and sale for KMTS over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See KMTS insider trades →

From SEC Form 4 filings by KMTS's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether KMTS is in one of them and how their past KMTS trades turned out.

KMTS in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered KMTS in an article yet. Here's the latest on the wider market.

About Kestra Medical Technologies

Kestra Medical Technologies is a medical device and digital health company based in Kirkland, Washington. It makes the ASSURE wearable cardioverter defibrillator, which is worn by patients at elevated risk of sudden cardiac arrest during recovery from heart problems. The company also offers a connected platform with a patient app, remote monitoring software for clinicians, and alert services that notify care teams when a shock is delivered. Its customers are patients and the healthcare providers who manage their cardiac care in the United States.

Headquarters
Kirkland, WA